SISatoru Ishida

Satoru Ishida

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Satoru Ishida has a total of 17 co-authors. Here are the top co-authors by number of shared publications:

  • Saori Nakano

    Clinical Research Center for Allergy and Rheumatology, National Hospital Organization, Sagamihara National Hospital, Sagamihara, Kanagawa, Japan

    2 shared publications
  • Shoji Yamane

    Clinical Research Center for Allergy and Rheumatology, National Hospital Organization, Sagamihara National Hospital, Sagamihara, Kanagawa, Japan

    2 shared publications
  • Takahiro Ochi

    Clinical Research Center for Allergy and Rheumatology, National Hospital Organization, Sagamihara National Hospital, Sagamihara, Kanagawa, Japan

    2 shared publications
  • Jun Ishizaki

    Discovery Research Laboratories, Shionogi & Co., Ltd., Toyonaka, Osaka, Japan

    1 shared publication
  • Miki Maeda‐Tanimura

    Discovery Research Laboratories, Shionogi & Co., Ltd., Toyonaka, Osaka, Japan

    1 shared publication
  • Naoshi Fukui

    Clinical Research Center for Allergy and Rheumatology, National Hospital Organization, Sagamihara National Hospital, Sagamihara, Kanagawa, Japan

    1 shared publication

Latest Publications

  • Open Access

    The interaction of monocytes with rheumatoid synovial cells is a key step in LIGHT‐mediated inflammatory bone destruction

    by Satoru Ishida, Shoji Yamane, Saori Nakano, Toru Yanagimoto, Yukie Hanamoto, Miki Maeda‐Tanimura, Tomoko Toyosaki‐Maeda, Jun Ishizaki, Yoshiyuki Matsuo, Naoshi Fukui, et al.

    Summary: Formation of osteoclasts and consequent joint destruction are hallmarks of rheumatoid arthritis (RA). Here we show that LIGHT, a member of the tumour necrosis factor (TNF) superfamily, induced the differentiation into tartrate‐resistant acid phosphatase (TRAP)‐positive multinucleated cells (MNCs) of CD14+ monocytes cocultured with nurse‐like cells isolated from RA synovium, but not of freshly isolated CD14+ monocytes. Receptor activator of nuclear factor‐κB ligand (RANKL) enhanced this LIGHT‐induced generation of TRAP‐positive MNCs. The MNCs showed the phenotypical and functional characteristics of osteoclasts; they showed the expression of osteoclast markers such as cathepsin K, actin‐ring formation, and the ability to resorb bone. Moreover, the MNCs expressed both matrix metalloproteinase 9 (MMP‐9) and MMP‐12, but the latter was not expressed in osteoclasts induced from CD14+ monocytes by RANKL. Immunohistochemical analysis showed that the MMP‐12‐producing MNCs were present in the erosive areas of joints in RA, but not in the affected joints of osteoarthritic patients. These findings suggested that LIGHT might be involved in the progression of inflammatory bone destruction in RA, and that osteoclast progenitors might become competent for LIGHT‐mediated osteoclastogenesis via interactions with synoviocyte‐like nurse‐like cells.


    • 15 April 2008
      • Vol. 35  (6) , 960-8

    LIGHT induces cell proliferation and inflammatory responses of rheumatoid arthritis synovial fibroblasts via lymphotoxin beta receptor.

    by Satoru Ishida, Shoji Yamane, Takahiro Ochi, Saori Nakano, Toshihito Mori, Takuo Juji, Naoshi Fukui, Tsunetoshi Itoh, Ryuji Suzuki

    To investigate the effects of LIGHT (lymphotoxin-like, exhibits inducible expression and competes with herpes simplex virus glycoprotein D for herpes virus entry mediator, a receptor expressed by T lymphocytes) on the proliferation and gene expression of fibroblast-like synoviocytes (FLS) from patients with rheumatoid arthritis (RA). We measured LIGHT levels in RA synovial fluids (SF) by ELISA, and compared them with those in osteoarthritis (OA) SF. Levels of LIGHT and its receptors in RA-FLS and synovium were assessed using real-time quantitative polymerase chain reaction (PCR). RA-FLS proliferation was examined by a bromodeoxyuridine assay. Expression of intercellular adhesion molecule-1 (ICAM-1) and several chemokines, such as interleukin 8 (IL-8), monocyte chemoattractant protein-1 (MCP-1), and macrophage inflammatory protein-1alpha (MIP-1alpha), was examined by real-time quantitative PCR, ELISA, and flow cytometry. The effects of LIGHT on nuclear factor-kappaB (NF-kappaB) activation were investigated using immunofluorescence and Western blotting. LIGHT was upregulated in both SF and synovium of RA patients compared with OA patients. Herpes virus entry mediator (HVEM) and lymphotoxin beta receptor (LTbetaR), but not LIGHT, were detected in RA-FLS. LIGHT significantly promoted RA-FLS proliferation and induced expression of MCP-1, IL-8, MIP-1alpha, and ICAM-1 by RA-FLS. As well, LTbetaR small interfering RNA (siRNA), but not HVEM siRNA, inhibited these effects of LIGHT. LIGHT induced IkappaBa degradation and NF-kappaB translocation, and a NF-kappaB inhibitor suppressed the effects of LIGHT on RA-FLS. Our findings suggest that LIGHT signaling via LTbetaR plays an important role in the pathogenesis of RA by affecting key processes such as the proliferation and activation of RA-FLS. Regulation of LIGHT-LTbetaR signaling may represent a new therapeutic target for RA treatment.